Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study.

Details

Language :

English

ISSN :

09564624

Volume :

35

Issue :

1

Database :

Complementary Index

Journal :

International Journal of STD & AIDS

Publication Type :

Academic Journal

Accession number :

174837723

Full Text :

https://doi.org/10.1177/09564624231196605